iStock Rating

B
Details...
Enter Symbol click to research

Novartis AG (NYSE: NVS)

Sector: Medical

Current Price : $88.21

52 Week Low
$58.97
52 Week High
$88.21
 

Blog Articles for NVS
Covestor.com image
Global Demand is Lifting Healthcare
By: Covestor.com
Publish Date: Wednesday, June 25, 2014
Stocks(s): ANIK, BIIB, NVS, PFE, SNY, TEVA
Sector(s): Medical

StreetAuthority image
GlaxoSmithKline (NYSE: GSK) Could Triple This Blue-Chip Stock's 4.6% Yield
By: StreetAuthority
Publish Date: Monday, May 19, 2014
Stocks(s): GSK, NVS
Sector(s): Medical

Jordan Kahn image
Jobs Growth Tepid At Best
By: Jordan Kahn
Publish Date: Tuesday, October 22, 2013
Stocks(s): AAMC, AAPL, CIT, COH, DAL, EMC, FCX, HOG
Sector(s): Finance, Computer and Technology, Basic Materials

StreetAuthority image
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE) and Bristol Myers Squibb Co. (BMY) : The Rebound May Be Over For Big Pharma
By: StreetAuthority
Publish Date: Tuesday, June 11, 2013
Stocks(s): BMY, LLY, MRK, NVS, PFE, RHHBY
Sector(s): Medical

Balachander image
Questcor Pharmaceuticals Inc (QCOR) Buys Rights To Develop Synacthen
By: Balachander
Publish Date: Tuesday, June 11, 2013
Stocks(s): NVS, QCOR
Sector(s): Medical

Dividend Growth Investor image
Johnson & Johnson (JNJ) - A Must Own Dividend Stock
By: Dividend Growth Investor
Publish Date: Friday, May 31, 2013
Stocks(s): BMY, JNJ, NVS, PFE
Sector(s): Medical

Balaseshan image
Actavis (ACT) Confirms Generic Version Of Novartis' (NVS) Dementia Therapy
By: Balaseshan
Publish Date: Friday, March 8, 2013
Stocks(s): ACT, NVS
Sector(s): Medical, Europe

Balaseshan image
Regeneron (REGN) To Receive Additional Royalty Stream On Acute Gouty Arthritis Drug Approval
By: Balaseshan
Publish Date: Monday, March 4, 2013
Stocks(s): NVS, REGN
Sector(s): Medical, Europe

Balaseshan image
PDL Biopharma (PDLI) 4Q Earnings Jump 27 Pct, Top Estimates
By: Balaseshan
Publish Date: Friday, March 1, 2013
Stocks(s): NVS, PDLI
Sector(s): Medical

Balachander image
FDA OKs Expanded Use Of Bayer/Onyx Drug For Rare Gastrointestinal Tumor
By: Balachander
Publish Date: Monday, February 25, 2013
Stocks(s): NVS, ONXX, PFE
Sector(s): Medical, Europe

Balaseshan image
Dendreon (DNDN) Sells New Jersey Facility To Novartis (NVS) Unit
By: Balaseshan
Publish Date: Thursday, December 20, 2012
Stocks(s): DNDN, NVS
Sector(s): Medical

iStockAnalyst image
Best Ways To Get Viking Exposure
By: iStockAnalyst
Publish Date: Thursday, November 15, 2012
Stocks(s): , NVS, PWT, RRX, WCP
Sector(s): Oils/Energy

Rich Bieglmeier image
The FDA Will Change Supernus Pharmaceuticals (SUPN) Stock Price - Soon
By: Rich Bieglmeier
Publish Date: Thursday, October 18, 2012
Stocks(s): NVS, SUPN
Sector(s): Medical, Trading Idea

Long-Term Investors image
Best Dividend Paying Stock List As Of October 2012
By: Long-Term Investors
Publish Date: Monday, October 1, 2012
Stocks(s): BHP, CHL, CVX, MXM, NVS, STO, STX, TLK
Sector(s): Computer and Technology, Basic Materials, Utilities

Balachander image
Futures Flat Ahead Of Manufacturing Data; Campbell Soup (CPB) Jumps
By: Balachander
Publish Date: Tuesday, September 4, 2012
Stocks(s): CLF, CPB, FNSR, MRX, NVS, PBY, PSS, SFD
Sector(s): Computer and Technology, Basic Materials, Retail/Wholesale

Balachander image
FDA Clears Roche’s Diabetic Eye Disease Treatment Lucentis
By: Balachander
Publish Date: Friday, August 10, 2012
Stocks(s): , NVS
Sector(s): Medical

Balachander image
Idenix Pharmaceuticals (IDIX) Prices 22M Share Offering At Discount
By: Balachander
Publish Date: Thursday, August 2, 2012
Stocks(s): IDIX, NVS
Sector(s): Medical

TheStockAdvisors.com image
4 Pharma Favorites With 4%+ Yields
By: TheStockAdvisors.com
Publish Date: Thursday, July 12, 2012
Stocks(s): , GSK, LLY, MRK, NVS
Sector(s): Medical

Ohad Hammer image
Winners Of ASCO 2012
By: Ohad Hammer
Publish Date: Thursday, June 14, 2012
Stocks(s): ARQL, ARRY, ASCO, AZN, BMS, BMY, EXEL, GSK
Sector(s): Medical, Industrial Products

Ohad Hammer image
Gilead’s Hematology Pipeline - Transformative And Under-Appreciated
By: Ohad Hammer
Publish Date: Wednesday, May 9, 2012
Stocks(s): EXEL, GILD, INCY, NVS, PCYC, RIGL, VRUS, YMI
Sector(s): Medical

Balaseshan image
Endo Pharmaceuticals (ENDP) Posts In-Line Q1 Earnings
By: Balaseshan
Publish Date: Tuesday, May 1, 2012
Stocks(s): ENDP, IPXL, NVS
Sector(s): Medical

iStockAnalyst image
Novartis (NVS) Gains After Afinitor Drug Approved By FDA To Treat Kidney Tumors
By: iStockAnalyst
Publish Date: Thursday, April 26, 2012
Stocks(s): NVS
Sector(s): Medical

iStockAnalyst image
Mylan (MYL): FDA Approves Generic Version Of Lescol Capsules
By: iStockAnalyst
Publish Date: Friday, April 13, 2012
Stocks(s): MYL, NVS
Sector(s): Medical

Investment U image
Healthcare Reform: Bad News For Big Pharma?
By: Investment U
Publish Date: Monday, April 2, 2012
Stocks(s): ABT, AZN, CIA, JNJ, LLY, MRK, NVS, PFE
Sector(s): Finance, Medical

Aleph Blog image
On Fourth Quarter 13Fs
By: Aleph Blog
Publish Date: Thursday, March 1, 2012
Stocks(s): AAPL, ACFC, AMED, AMR, AMZN, ARII, ARO, AVY
Sector(s): Finance, Computer and Technology, Basic Materials

PreviousPage 1 of 7Next
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.